All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Shop and compare

Skin

Prescription skincare for acne, rosacea, pigmentation, visible aging, and lash growth.

7

Products

0

Blends

7

Shoppable

FormBlends product finder

Browsing

Skin

Provider-reviewed

Licensed 503A pharmacy

Shop first

Browse Skin

Products are shown first. Research, mechanism notes, comparisons, and decision support stay below the shopping surface.

Showing 7 of 110
RxTretinoin Dermatology research profile visual summary
Dermatologysubscribe from $152

Tretinoin

20g tube

Prescription retinoid, compounded to your strength.

Texture and tone by ~week 6Decades of randomized trials
View product
RxTretinoin + Niacinamide Dermatology research profile visual summary
Dermatologysubscribe from $134

Tretinoin + Niacinamide

30g tube

Tretinoin, built to be tolerable enough to finish.

Smoother tone by ~week 6-8Retinoid + barrier-support pairing
View product
RxHydroquinone 8% Dermatology research profile visual summary
Dermatologysubscribe from $134

Hydroquinone 8%

30g tube

Prescription-strength brightening for stubborn pigment.

Spot lightening ~week 4-8Gold-standard depigmenting agent
View product
RxDapsone Acne Cream Dermatology research profile visual summary
Dermatologysubscribe from $179

Dapsone Acne Cream

30g tube

Prescription acne care for inflammation, not just clogged pores.

Inflammation eases ~week 4-8Anti-inflammatory acne agent
View product
RxRosacea Cream Dermatology research profile visual summary
Dermatologysubscribe from $152

Rosacea Cream

30g tube

Two rosacea mechanisms, compounded into one cream.

Redness calmer same dayTwo established rosacea mechanisms
View product
RxAzelaic Acid Cream Dermatology research profile visual summary
Dermatologysubscribe from $134

Azelaic Acid Cream

30g tube

One active for tone, redness and bumps at once.

Tone shifts ~week 6-12Multi-mechanism skin active
View product
RxLash Serum Dermatology research profile visual summary
Dermatologysubscribe from $206

Lash Serum

5 mL

The prescription active behind longer lashes.

Fuller lashes ~8-12 weeksFDA-approved active (as Latisse)
View product

Source reviewed

How to compare product options

FormBlends medical team | May 29, 2026

Shoppers comparing FormBlends GLP-1 programs, peptide bundles, and research profiles need a direct answer on fit first, then the evidence, timeline, and provider-review details that change the decision.

Answer who qualifies, what it costs, what forms exist, common side effects, and which alternatives to compare.

Put the practical answer near the top before the commercial call to action.

Link to dosing, safety, cost, and comparison guides that support the decision.

compare GLP-1 programs and peptides page visual summary
Visual summary for compare GLP-1 programs and peptides and the main search intent on this page.

Questions answered on this page

How do I choose between FormBlends GLP-1 programs and peptide bundles?
Use the evidence, safety, cost, access, and provider-review details on this page to evaluate the answer.
Which FormBlends products can I add to cart versus which require provider review?
Use the evidence, safety, cost, access, and provider-review details on this page to evaluate the answer.
How do semaglutide and tirzepatide programs compare on results and timeline?
Use the evidence, safety, cost, access, and provider-review details on this page to evaluate the answer.
What evidence and safety review backs each FormBlends product?
Use the evidence, safety, cost, access, and provider-review details on this page to evaluate the answer.

Finder facts for search and AI answers

What this product finder answers

Catalog scope

7 skin profiles

Prescription skincare for acne, rosacea, pigmentation, visible aging, and lash growth.

Clinical access

0 GLP-1 program profiles in this view

GLP-1 treatment paths require licensed-provider review for eligibility, contraindications, dosing, and side-effect management.

Research status

0 watchlist or research-only profiles in this view

Research/watchlist pages should not be treated as ordinary patient access pages.

Decision role

Compare goal fit, evidence strength, mechanism, timeline, and next step

The finder should route users into the right product page rather than making every product look equivalent.